Answers are grounded in this paper and cite their sources.
Observational analysis reveals remission of T-cell lymphoma in a man after methotrexate cessation, suggesting treatment-related risk.
Methotrexate (MTX) can cause MTX-associated lymphoproliferative disorders (MTX-LPDs) characterized by a T-cell phenotype. Herein, we report an extremely rare case of MTX-LPD with peripheral T-cell lymphoma (PTCL) phenotype and lung and skeletal muscle involvement. A 66-year-old man who had received MTX for 8 years for rheumatoid arthritis was admitted for right groin pain. A computed tomography scan revealed masses in the right middle lobe and right psoas muscle and multiple nodules in both lung fields. Pathological and immunohistochemical examinations of a lung nodule and psoas muscle tumor revealed PTCL. Remission was achieved soon after discontinuing MTX.
No takes yet. Share an insight, caveat, or question.
Arai et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: